Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

BACKGROUND: Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to the development of drug resistance remain unclear. METHODS: To better understand mechanisms of drug resistance, and possibly identify novel ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherman-Baust, Cheryl A, Becker, Kevin G, Wood III, William H, Zhang, Yongqing, Morin, Patrice J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259089/
https://www.ncbi.nlm.nih.gov/pubmed/22141344
http://dx.doi.org/10.1186/1757-2215-4-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259089/
https://www.ncbi.nlm.nih.gov/pubmed/22141344
http://dx.doi.org/10.1186/1757-2215-4-21

Ejemplares similares